Antihypertensive drugs: A perspective on the value of improved blood pressure control in the USA

European Heart Journal, Supplement

Volumn 9, Issue B, 2007, Pages

  Long, Genia ^a   Cutler, David M ^b   Berndt, Ernst R ^c  

^a ANALYSIS GROUP   (United States)

^b HARVARD UNIVERSITY   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Antihypertensives; Cost benefit; Hypertension; Myocardial infarction; Stroke

Indexed keywords

EID: 63849340320     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/sum004     Document Type: Review

References (17)

1. Cutler DM. Your Money or Your Life. New York: Oxford University Press; 2004.
2. Bruenn H. Clinical notes on the illness and death of President Franklin D. Roosevelt. Ann Int Med 1970;72:591.
3. Rice DP, Hodgson TA, Kopstein AN. The economic costs of illness: a replication and update. Health Care Financ Rev 1985;7:61-80.
4. Hodgson TA, Cohen AJ. Medical care expenditures for selected circulatory diseases: opportunities for reducing national health expenditures. Med Care 1999;37:994-1012.
5. Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D'Agostino RB, Levy D. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA 2002;287:1003-1010.
6. National Center for Health Statistics. Joint National Committee, "The fifth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure (JNCV)", Archives of Internal Medicine 1993;153:154-183.
7. Cutler DM, Long G, Berndt E, Royer J, Fournier AA, Sasser A, Cremieux P. The value of antihypertensive drugs: a perspective on medical innovation. Health Aff 2007;26:97-110.
8. NCHS. Deaths: final data for 1999. Natl Vital Stat Rep 1999;49.
9. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-1252.
10. Franco V, Oparil S, Carretero OA. Hypertensive therapy. Part II. Circulation 2004;109:3081-3088.
11. Hodgson TA, Cohen AJ. Medical care expenditures for selected circulatory diseases: opportunities for reducing national health expenditures. Medical Care 1999;37:994-1012. updated with 2002 data from the Centers for Medicare and Medicaid Services, 'National Health Expenditure Amounts, and Annual Percent Change by Type of Expenditure: Selected Calendar Years 1999-2015'. http://www.cms.hhs.gov/NationalHealthExpendData/downloads/proj2005.pdf(accessed 5 October 2006).
12. Ayanian JZ, Weissman JS, Schneider EC, Ginsburg JA, Zaslavsky AM. Unmet health needs of uninsured adults in the United States. JAMA 2000;284:2061-2069.
13. Huttin C, Moeller JF, Stafford RS. Patterns and costs for hypertension treatment in the United States. Clin Drug Investig 2000;20:181- 195.
14. Fish-Parcham C. Getting Less Care: the Uninsured with Chronic Health Conditions. Washington: Families USA Foundation; 2001.
15. J.P. Newhouse and the Insurance Experiment Group. Free for All: Lessons from the Rand Health Insurance Experiment. Cambridge: Harvard University Press; 1993.
16. Lurie N, Ward NB, Shapiro MF, Gallego C, Vaghaiwalla R, Brook RH. Termination from Medi-Cal: does it affect health? New Engl J Med 1986;314:1266-1268.
17. Rosen AB. Indications for and utilization of ACE inhibitors in older individuals with diabetes: findings from the National Health and Nutrition Examination Survey 1999 to 2002. J Gen Intern Med 2006;21:315-319.